About the journal
Bulletin du Cancer is a journal published by Elsevier BV in France. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 1,790 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 0007-4551 · 1769-6917
- Country
- France
- Access
- Not open access / not declared
- Declared publication charge
- 1,790 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.journals.elsevier.com/bulletin-du-cancer
Index listings
- MEDLINE · 1966-01-01
- PUBMED · 2004-05-01
- Indexing
- MEDLINE · PUBMED
- APC
- 1,790 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 89 days received→accepted — computed from PubMed (n=98)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
4970
Last recorded publication year
2026
h-index
38
i10-index
494
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 79%
- ORCID iDs in current deposits
- 32%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Source type
- journal
- NLM unique ID (PubMed)
- 0072416
- Society affiliations
- Société française du Cancer
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Health, Medicine and Society
- Health, Medicine and Society
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
Show all subjects (50)
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Multiple and Secondary Primary Cancers
- Multiple and Secondary Primary Cancers
- Healthcare Systems and Practices
- Healthcare Systems and Practices
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Ovarian cancer diagnosis and treatment
- Ovarian cancer diagnosis and treatment
- Cancer survivorship and care
- Cancer survivorship and care
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- CAR-T cell therapy research
- CAR-T cell therapy research
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Childhood Cancer Survivors' Quality of Life
- Endometrial and Cervical Cancer Treatments
- Childhood Cancer Survivors' Quality of Life
- Endometrial and Cervical Cancer Treatments
- Colorectal and Anal Carcinomas
- Colorectal and Anal Carcinomas
- Glioma Diagnosis and Treatment
- Educational Robotics and Engineering
- Glioma Diagnosis and Treatment
- Educational Robotics and Engineering
- Human auditory perception and evaluation
- Human auditory perception and evaluation
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ